How do I manage pediatric status epilepticus?

Summary

For children >1 month old with status epilepticus (i.e. seizure >5 minutes or recurrent seizures without full recovery), begin with supportive care (airway, breathing, circulation, rapid blood glucose check) then immediately initiate first‐line benzodiazepine therapy. Escalate to second‐line anti‐epileptics if seizures persist despite 2 doses.

Agents

Dose: If IV/IO access is available, give Lorazepam 0.1 mg/kg (max 4 mg) as a slow push; alternatively, if access is lacking, use Midazolam 0.2 mg/kg IM/intranasally (max 10 mg/dose)
When: Should be administered as soon as the seizure lasts >5 minutes, with a repeat dose if seizures persist after 3 minutes
Monitoring: Continuous cardiorespiratory monitoring (pulse oximetry, end-tidal CO₂ if available) and frequent neurologic assessments

Caution

Excessive dosing of benzodiazepines can lead to respiratory depression and require airway intervention^1
In toxin-induced seizures (e.g., cocaine toxicity), avoid agents like fosphenytoin that block sodium channels^3
Hemodynamic instability may occur with second-line agents (e.g., fosphenytoin), so monitor blood pressure closely

Targets

Goal: Terminate seizure activity promptly to minimize neuronal injury and multi-organ effects
Hold/stop if: Seizure activity ceases and the patient returns to baseline with maintained airway and stable hemodynamics

Dosing

Population	Dose	Max	Notes
Pediatric (Benzodiazepines)	Lorazepam 0.1 mg/kg IV/IO; OR Midazolam 0.2 mg/kg IM/IN	Lorazepam: 4 mg; Midazolam: 10 mg	First dose; may administer one repeat dose if seizures persist
Pediatric (Second-line options)	Levetiracetam 60 mg/kg IV/IO	4500 mg	Infuse over 5 minutes; preferred given rapid administration and favorable side effect profile ^1 ^4
	Fosphenytoin 20 mg PE/kg IV/IO	1500 mg	Infuse over 10 minutes; avoid in toxin-induced seizures
	Valproate 40 mg/kg IV/IO	3000 mg	Infuse over 10 minutes; use cautiously in patients with liver dysfunction
	Phenobarbital 20 mg/kg IV/IO	1000 mg	Infuse over 20 minutes; watch for respiratory depression (especially when combined with benzos)

Adjustments

Renal: Consider dose adjustments for Levetiracetam in renal impairment.
Hepatic: Use caution with Valproate in patients with hepatic dysfunction.
Obesity: Dosing remains weight-based; in obese patients, careful weight measurement is important for accurate dosing.

Adverse effects to watch for

Respiratory depression (especially with benzodiazepines and phenobarbital)
Hypotension during infusions of fosphenytoin or valproate
Excessive sedation, which may necessitate airway protection

Alternatives

If benzodiazepine first-line therapy fails and IV access delays second-line treatment, intranasal midazolam is an effective alternative.
Levetiracetam is favored as second-line therapy due to its rapid administration and lower drug–drug interaction potential.
If contraindications exist (e.g., liver dysfunction with valproate or toxin-induced seizures for fosphenytoin), adjust the choice of second-line agent accordingly ^1 ^5

^1 ^3 ^4 ^5

References

WIK
Status epilepticus (peds) from WikEM
WIK
Febrile seizure/en from WikEM
WIK
Status epilepticus from WikEM
PC
Status Epilepticus from PEM Currents
PP
Carpe Cerebrum: Seize the Brain from PEM Playbook

Powered by Cortex AI

We use advanced natural language processing to understand the nuance of complex medical queries, moving beyond keyword matching to true semantic understanding.

Semantic Search Real-time Indexing Mobile First

Query: "ED treatment exertional heat stroke"

Retrieving from: LITFL, EmCrit, IBCC...

Synthesized Clinical Answer